Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TSPO | P30536 | 3/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.37 |
| ▸ | TUBB | P07437 | 1/20 | 0.37 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.37 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.37 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.37 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.37 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.37 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10102354 | 0.84 | GAA (0.40) | GAASMN1; SMN2TSPOALPLMEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL30549287 | 0.82 | GAA (0.42) | GAASMN1; SMN2TSPOALPLMEN1 | |
| SCHEMBL7164942 | 0.81 | GAA (0.46) | GAASMN1; SMN2MEN1KMT2AHDAC3 | |
| SCHEMBL21311367 | 0.80 | SMN1; SMN2 (0.38) | GAASMN1; SMN2TSPOALPLMEN1 | |
| SCHEMBL474136 | 0.80 | POLB (0.46) | SMN1; SMN2MEN1KMT2ACNR1GPR55 | |
| SCHEMBL29699888 | 0.80 | POLB (0.46) | SMN1; SMN2MEN1KMT2ACNR1GPR55 | |
| SCHEMBL2877910 | 0.80 | — | — | |
| SCHEMBL22710664 | 0.78 | GAA (0.42) | GAASMN1; SMN2TSPOALPLMEN1 | |
| SCHEMBL8376596 | 0.78 | DRD2 (0.39) | MEN1KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL7207830 | 0.77 | GAA (0.39) | GAASMN1; SMN2TSPOALPLMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8535511-B2 | Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2013-09-17 | — | — | US | claimed |
| US-8008037-B2 | Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2011-08-30 | — | — | US | claimed |
| US-5492652-A | Dithiopentacene derivatives, their preparation and the use thereof as electron acceptors in charge transfer complexes | CIBA-GEIGY CORPORATION (US) | 1996-02-20 | — | — | US | claimed |
| US-5393606-A | Electroconductivity | CIBA-GEIGY CORPORATION (US) | 1995-02-28 | — | — | US | claimed |
| EP-0588759-A1 | Dithiopentacene derivatives, their preparation and their use in charge-transfer complexes | CIBA-GEIGY AG (CH) | 1994-03-23 | — | — | EP | claimed |
| EP-0573387-A2 | Charge-transfer complex with N-aromatic compounds, their preparation and their use | CIBA-GEIGY AG (CH) | 1993-12-08 | — | — | EP | claimed |
| WO-1993014185-A1 | CONVENIENT DETERMINATION OF TRACE LEAD IN WHOLE BLOOD AND OTHER FLUIDS | ANDCARE, INC. (US) | 1993-07-22 | — | — | WO | claimed |
| CN-117969634-A | Electrochemical detection method, device, equipment and medium for blood | 三诺生物传感股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2022109329-A1 | TRICYCLIC COMPOUNDS AND RELATED COMPOSITIONS, ZINC ELECTROCHEMICAL CELLS, BATTERIES, METHODS AND SYSTEMS | ALIONYX ENERGY SYSTEMS (US) | 2022-05-27 | — | — | WO | disclosed |
| US-11201293-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2021-12-14 | — | — | US | disclosed |
| CN-109863153-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2021-09-21 | — | — | CN | disclosed |
| CN-110511913-A | Saltant type glucose oxidase and its utilization | ARKRAY INC | 2019-11-29 | — | — | CN | disclosed |
| US-20190326517-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-10-24 | — | — | US | disclosed |
| WO-2001032211-A2 | CONJUGATE COMPOUNDS FOR TREATING ATHEROMA AND OTHER DISEASES | PHARMACYCLICS, INC. (US) | 2001-05-10 | — | — | WO | disclosed |
| US-5492652-A | Dithiopentacene derivatives, their preparation and the use thereof as electron acceptors in charge transfer complexes | CIBA-GEIGY CORPORATION (US) | 1996-02-20 | — | — | US | disclosed |
| EP-0671393-A1 | Monoaminophenazine leuco dyes and photothermographic materials containing same | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-09-13 | — | — | EP | disclosed |
| US-5436353-A | Dithiopentacene derivatives, their preparation and the use thereof as electron acceptors on charge transfer complexes | CIBA-GEIGY CORPORATION (US) | 1995-07-25 | — | — | US | disclosed |
| US-5393606-A | Electroconductivity | CIBA-GEIGY CORPORATION (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0588759-A1 | Dithiopentacene derivatives, their preparation and their use in charge-transfer complexes | CIBA-GEIGY AG (CH) | 1994-03-23 | — | — | EP | disclosed |
| EP-0573387-A2 | Charge-transfer complex with N-aromatic compounds, their preparation and their use | CIBA-GEIGY AG (CH) | 1993-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11201293-B2 | Heterocyclic compound and organic light-emitting device comprising same | CYP1A1, CRY1, CYP1B1 | GAA 2975/4885SMN1; SMN2 2498/4885TSPO 1602/4885 |
| US-20190326517-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CYP1A1, CRY1, CYP1B1 | GAA 2975/4885SMN1; SMN2 2498/4885TSPO 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.